08Mar 2023
Comparison Of 3-6 Month Versus 12 Month Dual Antiplatelet Therapy After Coronary Intervention Using the Contemporary Drug-eluting Stents With Ultrathin Struts

Comparison Of 3-6 Month Versus 12 Month Dual Antiplatelet Therapy After Coronary Intervention Using the Contemporary Drug-eluting Stents With Ultrathin Struts

This study aimed to compare the effectiveness of 3-6 month dual antiplatelet therapy (DAPT) versus 12-month DAPT after percutaneous coronary intervention (PCI) using third-generation drug-eluting stents with ultrathin struts and advanced polymer technology. The study included over 2,000 patients and found that 3-6 month DAPT was non-inferior to 12-month DAPT for net adverse clinical events (NACE), which included cardiac death, target vessel myocardial infarction, clinically driven target lesion revascularization, stent thrombosis, or major bleeding. The results suggest that shorter DAPT duration may be sufficient for these patients, but further research is needed to determine the ideal regimen.

  • #cardiology

Like

Save

Share